- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
According to our latest study, the global Platinum based Cancer Drug market size was valued at USD 1586.5 million in 2022 and is forecast to a readjusted size of USD 1896.7 million by 2029 with a CAGR of 2.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
This report is a detailed and comprehensive analysis for global Platinum based Cancer Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Platinum based Cancer Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Platinum based Cancer Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Platinum based Cancer Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Platinum based Cancer Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Platinum based Cancer Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Platinum based Cancer Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical and Qilu Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Platinum based Cancer Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Others
Market segment by Application
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
Major players covered
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Platinum based Cancer Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Platinum based Cancer Drug, with price, sales, revenue and global market share of Platinum based Cancer Drug from 2018 to 2023.
Chapter 3, the Platinum based Cancer Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Platinum based Cancer Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Platinum based Cancer Drug.
Chapter 14 and 15, to describe Platinum based Cancer Drug sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Platinum based Cancer Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Platinum based Cancer Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Cisplatin
1.3.3 Oxaliplatin
1.3.4 Carboplatin
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Platinum based Cancer Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Colorectal Cancer
1.4.3 Ovarian Cancer
1.4.4 Lung Cancer
1.4.5 Others
1.5 Global Platinum based Cancer Drug Market Size & Forecast
1.5.1 Global Platinum based Cancer Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Platinum based Cancer Drug Sales Quantity (2018-2029)
1.5.3 Global Platinum based Cancer Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Platinum based Cancer Drug Product and Services
2.1.4 Sanofi Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sanofi Recent Developments/Updates
2.2 Hengrui Medicine
2.2.1 Hengrui Medicine Details
2.2.2 Hengrui Medicine Major Business
2.2.3 Hengrui Medicine Platinum based Cancer Drug Product and Services
2.2.4 Hengrui Medicine Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Hengrui Medicine Recent Developments/Updates
2.3 ASK Pharma
2.3.1 ASK Pharma Details
2.3.2 ASK Pharma Major Business
2.3.3 ASK Pharma Platinum based Cancer Drug Product and Services
2.3.4 ASK Pharma Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ASK Pharma Recent Developments/Updates
2.4 Yi Bai Pharmaceutical
2.4.1 Yi Bai Pharmaceutical Details
2.4.2 Yi Bai Pharmaceutical Major Business
2.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Product and Services
2.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Yi Bai Pharmaceutical Recent Developments/Updates
2.5 Qilu Pharmaceutical
2.5.1 Qilu Pharmaceutical Details
2.5.2 Qilu Pharmaceutical Major Business
2.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Product and Services
2.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Qilu Pharmaceutical Recent Developments/Updates
2.6 Teva
2.6.1 Teva Details
2.6.2 Teva Major Business
2.6.3 Teva Platinum based Cancer Drug Product and Services
2.6.4 Teva Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Teva Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Platinum based Cancer Drug Product and Services
2.7.4 Pfizer Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Pfizer Recent Developments/Updates
2.8 Dr Reddy's Laboratories
2.8.1 Dr Reddy's Laboratories Details
2.8.2 Dr Reddy's Laboratories Major Business
2.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Product and Services
2.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Dr Reddy's Laboratories Recent Developments/Updates
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Platinum based Cancer Drug Product and Services
2.9.4 Mylan Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mylan Recent Developments/Updates
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business
2.10.3 Sun Pharma Platinum based Cancer Drug Product and Services
2.10.4 Sun Pharma Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Sun Pharma Recent Developments/Updates
2.11 Novartis
2.11.1 Novartis Details
2.11.2 Novartis Major Business
2.11.3 Novartis Platinum based Cancer Drug Product and Services
2.11.4 Novartis Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Novartis Recent Developments/Updates
2.12 Debiopharm
2.12.1 Debiopharm Details
2.12.2 Debiopharm Major Business
2.12.3 Debiopharm Platinum based Cancer Drug Product and Services
2.12.4 Debiopharm Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Debiopharm Recent Developments/Updates
2.13 Accord Healthcare
2.13.1 Accord Healthcare Details
2.13.2 Accord Healthcare Major Business
2.13.3 Accord Healthcare Platinum based Cancer Drug Product and Services
2.13.4 Accord Healthcare Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Accord Healthcare Recent Developments/Updates
2.14 SK Chemicals
2.14.1 SK Chemicals Details
2.14.2 SK Chemicals Major Business
2.14.3 SK Chemicals Platinum based Cancer Drug Product and Services
2.14.4 SK Chemicals Platinum based Cancer Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 SK Chemicals Recent Developments/Updates
3 Competitive Environment: Platinum based Cancer Drug by Manufacturer
3.1 Global Platinum based Cancer Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Platinum based Cancer Drug Revenue by Manufacturer (2018-2023)
3.3 Global Platinum based Cancer Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Platinum based Cancer Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Platinum based Cancer Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Platinum based Cancer Drug Manufacturer Market Share in 2022
3.5 Platinum based Cancer Drug Market: Overall Company Footprint Analysis
3.5.1 Platinum based Cancer Drug Market: Region Footprint
3.5.2 Platinum based Cancer Drug Market: Company Product Type Footprint
3.5.3 Platinum based Cancer Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Platinum based Cancer Drug Market Size by Region
4.1.1 Global Platinum based Cancer Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Platinum based Cancer Drug Consumption Value by Region (2018-2029)
4.1.3 Global Platinum based Cancer Drug Average Price by Region (2018-2029)
4.2 North America Platinum based Cancer Drug Consumption Value (2018-2029)
4.3 Europe Platinum based Cancer Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Platinum based Cancer Drug Consumption Value (2018-2029)
4.5 South America Platinum based Cancer Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Platinum based Cancer Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Platinum based Cancer Drug Sales Quantity by Type (2018-2029)
5.2 Global Platinum based Cancer Drug Consumption Value by Type (2018-2029)
5.3 Global Platinum based Cancer Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Platinum based Cancer Drug Sales Quantity by Application (2018-2029)
6.2 Global Platinum based Cancer Drug Consumption Value by Application (2018-2029)
6.3 Global Platinum based Cancer Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Platinum based Cancer Drug Sales Quantity by Type (2018-2029)
7.2 North America Platinum based Cancer Drug Sales Quantity by Application (2018-2029)
7.3 North America Platinum based Cancer Drug Market Size by Country
7.3.1 North America Platinum based Cancer Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Platinum based Cancer Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Platinum based Cancer Drug Sales Quantity by Type (2018-2029)
8.2 Europe Platinum based Cancer Drug Sales Quantity by Application (2018-2029)
8.3 Europe Platinum based Cancer Drug Market Size by Country
8.3.1 Europe Platinum based Cancer Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Platinum based Cancer Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Platinum based Cancer Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Platinum based Cancer Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Platinum based Cancer Drug Market Size by Region
9.3.1 Asia-Pacific Platinum based Cancer Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Platinum based Cancer Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Platinum based Cancer Drug Sales Quantity by Type (2018-2029)
10.2 South America Platinum based Cancer Drug Sales Quantity by Application (2018-2029)
10.3 South America Platinum based Cancer Drug Market Size by Country
10.3.1 South America Platinum based Cancer Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Platinum based Cancer Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Platinum based Cancer Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Platinum based Cancer Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Platinum based Cancer Drug Market Size by Country
11.3.1 Middle East & Africa Platinum based Cancer Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Platinum based Cancer Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Platinum based Cancer Drug Market Drivers
12.2 Platinum based Cancer Drug Market Restraints
12.3 Platinum based Cancer Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Platinum based Cancer Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Platinum based Cancer Drug
13.3 Platinum based Cancer Drug Production Process
13.4 Platinum based Cancer Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Platinum based Cancer Drug Typical Distributors
14.3 Platinum based Cancer Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Platinum based Cancer Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Platinum based Cancer Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Platinum based Cancer Drug Product and Services
Table 6. Sanofi Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sanofi Recent Developments/Updates
Table 8. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 9. Hengrui Medicine Major Business
Table 10. Hengrui Medicine Platinum based Cancer Drug Product and Services
Table 11. Hengrui Medicine Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Hengrui Medicine Recent Developments/Updates
Table 13. ASK Pharma Basic Information, Manufacturing Base and Competitors
Table 14. ASK Pharma Major Business
Table 15. ASK Pharma Platinum based Cancer Drug Product and Services
Table 16. ASK Pharma Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ASK Pharma Recent Developments/Updates
Table 18. Yi Bai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Yi Bai Pharmaceutical Major Business
Table 20. Yi Bai Pharmaceutical Platinum based Cancer Drug Product and Services
Table 21. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Yi Bai Pharmaceutical Recent Developments/Updates
Table 23. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Qilu Pharmaceutical Major Business
Table 25. Qilu Pharmaceutical Platinum based Cancer Drug Product and Services
Table 26. Qilu Pharmaceutical Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Qilu Pharmaceutical Recent Developments/Updates
Table 28. Teva Basic Information, Manufacturing Base and Competitors
Table 29. Teva Major Business
Table 30. Teva Platinum based Cancer Drug Product and Services
Table 31. Teva Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Teva Recent Developments/Updates
Table 33. Pfizer Basic Information, Manufacturing Base and Competitors
Table 34. Pfizer Major Business
Table 35. Pfizer Platinum based Cancer Drug Product and Services
Table 36. Pfizer Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Pfizer Recent Developments/Updates
Table 38. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Dr Reddy's Laboratories Major Business
Table 40. Dr Reddy's Laboratories Platinum based Cancer Drug Product and Services
Table 41. Dr Reddy's Laboratories Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Dr Reddy's Laboratories Recent Developments/Updates
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Platinum based Cancer Drug Product and Services
Table 46. Mylan Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Mylan Recent Developments/Updates
Table 48. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Sun Pharma Major Business
Table 50. Sun Pharma Platinum based Cancer Drug Product and Services
Table 51. Sun Pharma Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Sun Pharma Recent Developments/Updates
Table 53. Novartis Basic Information, Manufacturing Base and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Platinum based Cancer Drug Product and Services
Table 56. Novartis Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Novartis Recent Developments/Updates
Table 58. Debiopharm Basic Information, Manufacturing Base and Competitors
Table 59. Debiopharm Major Business
Table 60. Debiopharm Platinum based Cancer Drug Product and Services
Table 61. Debiopharm Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Debiopharm Recent Developments/Updates
Table 63. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 64. Accord Healthcare Major Business
Table 65. Accord Healthcare Platinum based Cancer Drug Product and Services
Table 66. Accord Healthcare Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Accord Healthcare Recent Developments/Updates
Table 68. SK Chemicals Basic Information, Manufacturing Base and Competitors
Table 69. SK Chemicals Major Business
Table 70. SK Chemicals Platinum based Cancer Drug Product and Services
Table 71. SK Chemicals Platinum based Cancer Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. SK Chemicals Recent Developments/Updates
Table 73. Global Platinum based Cancer Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Platinum based Cancer Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Platinum based Cancer Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 76. Market Position of Manufacturers in Platinum based Cancer Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Platinum based Cancer Drug Production Site of Key Manufacturer
Table 78. Platinum based Cancer Drug Market: Company Product Type Footprint
Table 79. Platinum based Cancer Drug Market: Company Product Application Footprint
Table 80. Platinum based Cancer Drug New Market Entrants and Barriers to Market Entry
Table 81. Platinum based Cancer Drug Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Platinum based Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Platinum based Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Platinum based Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Platinum based Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Platinum based Cancer Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 87. Global Platinum based Cancer Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 88. Global Platinum based Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Platinum based Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Platinum based Cancer Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Platinum based Cancer Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Platinum based Cancer Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 93. Global Platinum based Cancer Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 94. Global Platinum based Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Platinum based Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Platinum based Cancer Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Platinum based Cancer Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Platinum based Cancer Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 99. Global Platinum based Cancer Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 100. North America Platinum based Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Platinum based Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Platinum based Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Platinum based Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Platinum based Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Platinum based Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Platinum based Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Platinum based Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Platinum based Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Platinum based Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Platinum based Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Platinum based Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Platinum based Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Platinum based Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Platinum based Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Platinum based Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Platinum based Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Platinum based Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Platinum based Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Platinum based Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Platinum based Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Platinum based Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Platinum based Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Platinum based Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Platinum based Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Platinum based Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Platinum based Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Platinum based Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Platinum based Cancer Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Platinum based Cancer Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Platinum based Cancer Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Platinum based Cancer Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Platinum based Cancer Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Platinum based Cancer Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Platinum based Cancer Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Platinum based Cancer Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Platinum based Cancer Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Platinum based Cancer Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Platinum based Cancer Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Platinum based Cancer Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Platinum based Cancer Drug Raw Material
Table 141. Key Manufacturers of Platinum based Cancer Drug Raw Materials
Table 142. Platinum based Cancer Drug Typical Distributors
Table 143. Platinum based Cancer Drug Typical Customers
List of Figures
Figure 1. Platinum based Cancer Drug Picture
Figure 2. Global Platinum based Cancer Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Platinum based Cancer Drug Consumption Value Market Share by Type in 2022
Figure 4. Cisplatin Examples
Figure 5. Oxaliplatin Examples
Figure 6. Carboplatin Examples
Figure 7. Others Examples
Figure 8. Global Platinum based Cancer Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Platinum based Cancer Drug Consumption Value Market Share by Application in 2022
Figure 10. Colorectal Cancer Examples
Figure 11. Ovarian Cancer Examples
Figure 12. Lung Cancer Examples
Figure 13. Others Examples
Figure 14. Global Platinum based Cancer Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Platinum based Cancer Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Platinum based Cancer Drug Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Platinum based Cancer Drug Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Platinum based Cancer Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Platinum based Cancer Drug Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Platinum based Cancer Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Platinum based Cancer Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Platinum based Cancer Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Platinum based Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Platinum based Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Platinum based Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Platinum based Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Platinum based Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Platinum based Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Platinum based Cancer Drug Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Platinum based Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Platinum based Cancer Drug Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Platinum based Cancer Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Platinum based Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Platinum based Cancer Drug Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Platinum based Cancer Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Platinum based Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Platinum based Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Platinum based Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Platinum based Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Platinum based Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Platinum based Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Platinum based Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Platinum based Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Platinum based Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Platinum based Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Platinum based Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Platinum based Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 56. China Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Platinum based Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Platinum based Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Platinum based Cancer Drug Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Platinum based Cancer Drug Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Platinum based Cancer Drug Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Platinum based Cancer Drug Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Platinum based Cancer Drug Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Platinum based Cancer Drug Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Platinum based Cancer Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Platinum based Cancer Drug Market Drivers
Figure 77. Platinum based Cancer Drug Market Restraints
Figure 78. Platinum based Cancer Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Platinum based Cancer Drug in 2022
Figure 81. Manufacturing Process Analysis of Platinum based Cancer Drug
Figure 82. Platinum based Cancer Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
